Your session is about to expire
← Back to Search
Cancer Vaccine
Papilloma Virus Vaccine for Laryngeal Warts
Phase 2
Waitlist Available
Research Sponsored by University of Medicine and Dentistry of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
DISEASE CHARACTERISTICS: Diagnosis of severe recurrent juvenile papilloma of the larynx requiring surgery at least 4 times per year Condition must have existed for more than 1 year
PATIENT CHARACTERISTICS: Age: 1 and over Performance status: Not specified Life expectancy: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is testing a papilloma virus vaccine to see if it is effective in treating young patients with recurrent papilloma of the larynx.
Who is the study for?
This trial is for young patients with severe recurrent juvenile papilloma of the larynx, which causes growths in the throat and requires surgery at least four times a year. The condition should have persisted for over a year. There are no specific requirements regarding age (other than being over 1), life expectancy, or organ function.Check my eligibility
What is being tested?
The study is testing a vaccine made from papilloma virus cells to see if it can stimulate the body's immune system to fight off and potentially kill papilloma cells in young patients with recurrent growths in their throats.See study design
What are the potential side effects?
While not explicitly listed, vaccines like this could cause side effects such as soreness at injection site, fever, fatigue, headache and allergic reactions. More serious side effects may include an immune response that affects other parts of the body.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
University of Medicine and Dentistry of New JerseyLead Sponsor
121 Previous Clinical Trials
13,286 Total Patients Enrolled
1 Trials studying Precancerous Conditions
James M. Oleske, MDStudy ChairRutgers, The State University of New Jersey
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had severe throat growths needing surgery 4+ times a year for over a year.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What level of security does this therapy present for those receiving it?
"Taking into account that it is a Phase 2 trial, and thus lacks evidence of efficacy but has some data supporting safety, we have estimated this treatment's security at a level-2."
Answered by AI
Has enrollment for this trial commenced yet?
"Confirmation of this can be found on clinicaltrials.gov; the trial is not currently recruiting, having been initially posted in December 1971 and last updated eight years ago. However, there are 84 other investigations actively accepting patients at present."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger